Cargando…
Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways
Pancreatic cancer (PanCa) presents a catastrophic disease with poor overall survival at advanced stages, with immediate requirement of new and effective treatment options. Besides genetic mutations, epigenetic dysregulation of signaling pathway-associated enriched genes are considered as novel thera...
Autores principales: | Bararia, Akash, Das, Amlan, Mitra, Sangeeta, Banerjee, Sudeep, Chatterjee, Aniruddha, Sikdar, Nilabja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514732/ https://www.ncbi.nlm.nih.gov/pubmed/37746645 http://dx.doi.org/10.4251/wjgo.v15.i9.1505 |
Ejemplares similares
-
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer
por: Bararia, Akash, et al.
Publicado: (2023) -
DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort
por: Chatterjee, Ankita, et al.
Publicado: (2022) -
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
por: Sikdar, Nilabja, et al.
Publicado: (2018) -
On the Nature of the Deoxyribonucleic Acid-Methyl Green Reaction
por: Rosenkranz, Herbert S., et al.
Publicado: (1958) -
Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy
por: Luo, Hao-Yun, et al.
Publicado: (2022)